Cited 21 times in
Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 배미경 | - |
dc.contributor.author | 이진구 | - |
dc.contributor.author | 이창영 | - |
dc.contributor.author | 정경영 | - |
dc.contributor.author | 김대준 | - |
dc.contributor.author | 박인규 | - |
dc.date.accessioned | 2015-05-19T17:15:04Z | - |
dc.date.available | 2015-05-19T17:15:04Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1556-0864 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/107790 | - |
dc.description.abstract | OBJECTIVE: This study was conducted to assess the validity of the pending suggestions for N descriptors by the International Association for the Study of Lung Cancer. METHODS: Medical records from 1032 patients with non-small cell lung cancer who had pulmonary resection and proven stage I-III were retrospectively reviewed. Lymph node stations were grouped together into six "zones": peripheral or hilar for N1 and upper or lower mediastinal, aortopulmonary, and subcarinal for N2. Survival was analyzed according to the proposed subdividing N descriptors: single-zone N1 (N1a), multizone N1 (N1b), single-zone N2 (N2a), and multizone N2 (N2b). RESULTS: The 5-year survival rate was 63.8% for N0, 42.3% for N1a, 36.5% for N1b, 35.8% for N2a, and 17.4% for N2b. There were three distinct prognostic groups for N1 and N2 nodes: N1a, N1b or N2a, and N2b disease. In multivariate analysis, age, sex, type of surgery, T stage, and node status were independent prognostic factors. Hazard ratios versus N0 for N1a, N1b or N2b, N2b, and N3 were 1.577, 2.164, 3.291, and 5.897, respectively. CONCLUSION: Amalgamating lymph node stations into zones and subdividing N descriptors described a significant stepwise deterioration of disease status. Although more studies are needed, the lymph node zone and subdivided N descriptors could be one of step for desirable approach of forthcoming tumor, node, metastasis classification in non-small cell lung cancer. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1421~1426 | - |
dc.relation.isPartOf | JOURNAL OF THORACIC ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adenocarcinoma/classification | - |
dc.subject.MESH | Adenocarcinoma/secondary | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Carcinoma, Large Cell/classification | - |
dc.subject.MESH | Carcinoma, Large Cell/secondary | - |
dc.subject.MESH | Carcinoma, Non-Small-Cell Lung/classification* | - |
dc.subject.MESH | Carcinoma, Non-Small-Cell Lung/secondary | - |
dc.subject.MESH | Carcinoma, Squamous Cell/classification | - |
dc.subject.MESH | Carcinoma, Squamous Cell/secondary | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | International Cooperation* | - |
dc.subject.MESH | Lung Neoplasms/classification* | - |
dc.subject.MESH | Lung Neoplasms/pathology | - |
dc.subject.MESH | Lymphatic Metastasis | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Staging | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Survival Rate | - |
dc.title | Validity of International Association for the Study Of Lung Cancer proposals for the revision of N descriptors in lung cancer. | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Thoracic & Cardiovascular Surgery (흉부외과학) | - |
dc.contributor.googleauthor | Jin Gu Lee | - |
dc.contributor.googleauthor | Chang Young Lee | - |
dc.contributor.googleauthor | Mi Kyung Bae | - |
dc.contributor.googleauthor | In Kyu Park | - |
dc.contributor.googleauthor | Dae Joon Kim | - |
dc.contributor.googleauthor | Kil Dong Kim | - |
dc.contributor.googleauthor | Kyung Young Chung | - |
dc.identifier.doi | 10.1097/JTO.0b013e31818e0dbd | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01792 | - |
dc.contributor.localId | A03225 | - |
dc.contributor.localId | A03245 | - |
dc.contributor.localId | A03571 | - |
dc.contributor.localId | A00368 | - |
dc.contributor.localId | A01625 | - |
dc.relation.journalcode | J01909 | - |
dc.identifier.eissn | 1556-1380 | - |
dc.identifier.pmid | 19057267 | - |
dc.identifier.url | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=01243894-200812000-00011&LSLINK=80&D=ovft | - |
dc.subject.keyword | Lung cancer | - |
dc.subject.keyword | Lymph nodes | - |
dc.subject.keyword | Zone | - |
dc.subject.keyword | Outcome | - |
dc.contributor.alternativeName | Bae, Mi Kyung | - |
dc.contributor.alternativeName | Lee, Jin Gu | - |
dc.contributor.alternativeName | Lee, Chang Young | - |
dc.contributor.alternativeName | Chung, Kyung Young | - |
dc.contributor.alternativeName | Kim, Dae Joon | - |
dc.contributor.alternativeName | Park, In Kyu | - |
dc.contributor.affiliatedAuthor | Bae, Mi Kyung | - |
dc.contributor.affiliatedAuthor | Lee, Jin Gu | - |
dc.contributor.affiliatedAuthor | Lee, Chang Young | - |
dc.contributor.affiliatedAuthor | Chung, Kyung Young | - |
dc.contributor.affiliatedAuthor | Kim, Dae Joon | - |
dc.contributor.affiliatedAuthor | Park, In Kyu | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 3 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1421 | - |
dc.citation.endPage | 1426 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THORACIC ONCOLOGY, Vol.3(12) : 1421-1426, 2008 | - |
dc.identifier.rimsid | 34687 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.